跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELZONRIS 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ELZONRIS 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
ELZONRIS 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Stemline Therapeutics B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 20, 2023
Approval ID
d06ffe56a888b862
Company
Stemline Therapeutics B.V.
Type
Standard
Approval Details
Approval Id
d06ffe56a888b862
Drug Cima Aemps Name
ELZONRIS 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201504001
Holder Company Name
Stemline Therapeutics B.V.
Marketing Company Name
Menarini Stemline Espana S.L.
Holder Company Detail Path
/organization/stemline-therapeutics-bv
Authorization Date
2023-10-20
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
1 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Stemline Therapeutics B.V.
Company Detail Path
/organization/stemline-therapeutics-bv
Company Information
Pharmaceutical Company Name
Stemline Therapeutics BV
Country Name
Netherlands
Active Ingredients
TAGRAXOFUSP
1 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 20, 2023
Approval ID
d06ffe56a888b862
Type
Standard
Back to CIMA-AEMPS Approvals